Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study

DA Fennell; P Baas; P Taylor; AK Nowak; D Gilligan; T Nakano; JA Pachter; DT Weaver; A Scherpereel; N Pavlakis; JP van Meerbeeck; S Cedres; L Nolan; H Kindler; Joachim Aerts

doi:10.1200/jco.2018.79.0543

Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study

DA Fennell, P Baas, P Taylor, AK Nowak, D Gilligan, T Nakano, JA Pachter, DT Weaver, A Scherpereel, N Pavlakis, JP van Meerbeeck, S Cedres, L Nolan, H Kindler, Joachim Aerts

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

91 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	790-+
Journal	Journal of Clinical Oncology
Volume	37
Issue number	10
DOIs	https://doi.org/10.1200/jco.2018.79.0543
Publication status	Published - 2019

Research programs

EMC MM-04-42-02

Access to Document

10.1200/jco.2018.79.0543

http://hdl.handle.net/1765/116141

Cite this

Fennell, DA., Baas, P., Taylor, P., Nowak, AK., Gilligan, D., Nakano, T., Pachter, JA., Weaver, DT., Scherpereel, A., Pavlakis, N., van Meerbeeck, JP., Cedres, S., Nolan, L., Kindler, H., & Aerts, J. (2019). Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study. Journal of Clinical Oncology, 37(10), 790-+. https://doi.org/10.1200/jco.2018.79.0543

@article{f313615242f0452fb2651432ea7975e8,

title = "Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study",

author = "DA Fennell and P Baas and P Taylor and AK Nowak and D Gilligan and T Nakano and JA Pachter and DT Weaver and A Scherpereel and N Pavlakis and {van Meerbeeck}, JP and S Cedres and L Nolan and H Kindler and Joachim Aerts",

year = "2019",

doi = "10.1200/jco.2018.79.0543",

language = "Undefined/Unknown",

volume = "37",

pages = "790--+",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "10",

}

Fennell, DA, Baas, P, Taylor, P, Nowak, AK, Gilligan, D, Nakano, T, Pachter, JA, Weaver, DT, Scherpereel, A, Pavlakis, N, van Meerbeeck, JP, Cedres, S, Nolan, L, Kindler, H & Aerts, J 2019, 'Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study', Journal of Clinical Oncology, vol. 37, no. 10, pp. 790-+. https://doi.org/10.1200/jco.2018.79.0543

TY - JOUR

T1 - Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study

AU - Fennell, DA

AU - Baas, P

AU - Taylor, P

AU - Nowak, AK

AU - Gilligan, D

AU - Nakano, T

AU - Pachter, JA

AU - Weaver, DT

AU - Scherpereel, A

AU - Pavlakis, N

AU - van Meerbeeck, JP

AU - Cedres, S

AU - Nolan, L

AU - Kindler, H

AU - Aerts, Joachim

PY - 2019

Y1 - 2019

U2 - 10.1200/jco.2018.79.0543

DO - 10.1200/jco.2018.79.0543

M3 - Article

SN - 0732-183X

VL - 37

SP - 790-+

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 10

ER -